GB0129876D0 - Novel pharmaceutical - Google Patents

Novel pharmaceutical

Info

Publication number
GB0129876D0
GB0129876D0 GBGB0129876.9A GB0129876A GB0129876D0 GB 0129876 D0 GB0129876 D0 GB 0129876D0 GB 0129876 A GB0129876 A GB 0129876A GB 0129876 D0 GB0129876 D0 GB 0129876D0
Authority
GB
United Kingdom
Prior art keywords
novel pharmaceutical
pharmaceutical
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0129876.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0129876.9A priority Critical patent/GB0129876D0/en
Publication of GB0129876D0 publication Critical patent/GB0129876D0/en
Priority to PCT/GB2002/005672 priority patent/WO2003050112A1/fr
Priority to AU2002350964A priority patent/AU2002350964A1/en
Priority to PCT/GB2002/005671 priority patent/WO2003050111A1/fr
Priority to AU2002350965A priority patent/AU2002350965A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0129876.9A 2001-12-13 2001-12-13 Novel pharmaceutical Ceased GB0129876D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0129876.9A GB0129876D0 (en) 2001-12-13 2001-12-13 Novel pharmaceutical
PCT/GB2002/005672 WO2003050112A1 (fr) 2001-12-13 2002-12-13 Hydrates de toluenesulfonate d'un derive de thiazolidinedione
AU2002350964A AU2002350964A1 (en) 2001-12-13 2002-12-13 Toluenesulfonate salts of a thiazolidinedione derivative
PCT/GB2002/005671 WO2003050111A1 (fr) 2001-12-13 2002-12-13 Sels de type toluenesulfonate issus d'un derive de la thiazolidinedione
AU2002350965A AU2002350965A1 (en) 2001-12-13 2002-12-13 Toluenesulfonate hydrates of a thiazolidinedione derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0129876.9A GB0129876D0 (en) 2001-12-13 2001-12-13 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
GB0129876D0 true GB0129876D0 (en) 2002-02-06

Family

ID=9927583

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0129876.9A Ceased GB0129876D0 (en) 2001-12-13 2001-12-13 Novel pharmaceutical

Country Status (3)

Country Link
AU (1) AU2002350964A1 (fr)
GB (1) GB0129876D0 (fr)
WO (1) WO2003050111A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA91520C2 (en) 2004-09-29 2010-08-10 Баер Шеринг Фарма Акциенгезельшафт Thermodynamically stable form of tosylate
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
AU2002350964A1 (en) 2003-06-23
WO2003050111A1 (fr) 2003-06-19

Similar Documents

Publication Publication Date Title
EP1450824A4 (fr) Composition pharmaceutique
GB0104534D0 (en) Pharmaceutical combination
PL366510A1 (en) Pharmaceutical combinations
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
EP1408896A4 (fr) Composition pharmaceutique
GB0101225D0 (en) Pharmaceutical compounds
GB0101227D0 (en) Pharmaceutical compounds
GB0129117D0 (en) Pharmaceutical composition
GB0124523D0 (en) Pharmaceutical combination
GB0116107D0 (en) Pharmaceutical composition
GB0127805D0 (en) Pharmaceutical composition
PL370037A1 (en) Pharmaceutical composition
GB0129270D0 (en) Pharmaceutical combination
GB0129397D0 (en) Pharmaceutical combination
GB0129872D0 (en) Novel pharmaceutical
GB0129395D0 (en) Pharmaceutical combination
GB0130510D0 (en) Novel pharmaceutical
GB0129876D0 (en) Novel pharmaceutical
GB0130511D0 (en) Novel pharmaceutical
GB0130509D0 (en) Novel pharmaceutical
IL157411A0 (en) Pharmaceutical composition
GB0111709D0 (en) Novel pharmaceuticals
GB0128138D0 (en) Pharmaceutical use
GB0129871D0 (en) Novel pharmaceutical

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)